Investigating the Next Wave of Innovation to Help People with Hemophilia
Watch below.
September Social Media Round-Up—Prostate Cancer Awareness, TIME Executives of the Year, and More
As we enter fall, the days are getting shorter and the nights are getting cooler, but Pfizer’s social media channels are as active as ever.
September Social Media Round-Up—Prostate Cancer Awareness, TIME Executives of the Year, and More
As we enter fall, the days are getting shorter and the nights are getting cooler, but Pfizer’s social media channels are as active as ever.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises
Pfizer conducted a global online survey exploring the challenges of hemophilia as well as the priorities that shape treatment decisions and considerations for change.
Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises
Pfizer conducted a global online survey exploring the challenges of hemophilia as well as the priorities that shape treatment decisions and considerations for change.
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.
September Social Media Round-Up—Prostate Cancer Awareness, TIME Executives of the Year, and More
As we enter fall, the days are getting shorter and the nights are getting cooler, but Pfizer’s social media channels are as active as ever.
September Social Media Round-Up—Prostate Cancer Awareness, TIME Executives of the Year, and More
As we enter fall, the days are getting shorter and the nights are getting cooler, but Pfizer’s social media channels are as active as ever.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises
Pfizer conducted a global online survey exploring the challenges of hemophilia as well as the priorities that shape treatment decisions and considerations for change.
Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises
Pfizer conducted a global online survey exploring the challenges of hemophilia as well as the priorities that shape treatment decisions and considerations for change.
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.